Thermo Fisher RapidINTEL Plus Cartridge gains FBI approval for forensic use

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights

Thermo Fisher Scientific's Applied Biosystems RapidINTEL Plus Cartridge received FBI NDIS approval for forensic crime scene samples, making its Rapid DNA workflow the first eligible for CODIS database searches. This allows law enforcement to generate and search DNA profiles in hours, significantly accelerating investigations.

powered bylight_fuzz_icon
44981250

*this image is generated using AI for illustrative purposes only.

Thermo Fisher Scientific announced that its Applied Biosystems RapidINTEL Plus Cartridge has received approval from the Federal Bureau of Investigation (FBI) National DNA Index System (NDIS) for use with qualifying forensic crime scene samples. This regulatory milestone allows the company's Rapid DNA workflow on the RapidHIT ID System to become the first eligible to generate DNA profiles that can be searched against the national CODIS database network when FBI requirements are met. The approval significantly accelerates access to investigative DNA intelligence, reducing the time required from days or weeks to just hours.

The FBI's NDIS approval validates the technical capabilities of the RapidINTEL Plus Cartridge within the RapidHIT ID System for forensic applications. By meeting the stringent requirements set by the FBI, the system enables law enforcement agencies to process crime scene samples more efficiently. The ability to rapidly generate and search DNA profiles against the CODIS database enhances the speed and accuracy of criminal investigations.

The Rapid DNA workflow facilitated by the RapidHIT ID System is designed to streamline the DNA profiling process. The inclusion of the RapidINTEL Plus Cartridge in the NDIS approval expands the scope of samples that can be processed rapidly. This development is expected to support law enforcement agencies in time-sensitive investigations where quick DNA analysis is critical.

Key Features of the Approved System

Feature Description
System RapidHIT ID System
Cartridge Applied Biosystems RapidINTEL Plus Cartridge
Approval Authority FBI National DNA Index System (NDIS)
Database Access CODIS network
Processing Time Hours

The approval marks a significant advancement in forensic technology, providing law enforcement with a powerful tool for rapid DNA analysis. Thermo Fisher Scientific continues to innovate in the field of forensic science, delivering solutions that enhance the capabilities of investigative agencies.

How will this approval impact Thermo Fisher's market share in the forensic DNA analysis sector?

What are the potential cost implications for law enforcement agencies adopting this rapid DNA technology?

Could this approval lead to similar regulatory milestones in international markets?

like19
dislike

Evercore ISI Group maintains Outperform on Thermo Fisher Scientific

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Evercore ISI Group analyst Vijay Kumar maintained an Outperform rating on Thermo Fisher Scientific but lowered the price target to $570 from $575.

powered bylight_fuzz_icon
44912998

*this image is generated using AI for illustrative purposes only.

Evercore ISI Group analyst Vijay Kumar has maintained an Outperform rating for Thermo Fisher Scientific while adjusting the stock's valuation expectations. The firm lowered the price target to $570, down from the previous $575, reflecting a revised outlook on the company's shares.

Rating and Price Target Adjustment

The research note affirms the positive stance on Thermo Fisher Scientific despite the reduction in the price objective. The new target of $570 represents a slight decrease from the prior $575 level set by the analyst.

Metric Value
Rating Outperform
Previous Price Target $575
New Price Target $570

What specific factors drove Evercore ISI to revise the price target slightly lower while maintaining an Outperform rating?

How might Thermo Fisher's upcoming earnings report influence the stock's performance relative to the new $570 target?

What are the key growth catalysts for Thermo Fisher that could justify the Outperform rating in the current market environment?

like19
dislike

More News on Thermo Fisher Scientific Inc